,59,60 It has previously been hypothesized that the outcome of loss-of-function PRKN mutations are highly cell-context dependent; the increased half-life of cyclins leads to cancer in mitotically competent cells while the same cyclins may promote apoptosis upon cell cycle reentry in post-mitotic cells, such as neurons.57 The gene discussed is PRKN; the disease is cancer.